Management of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors

Management of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors

Immune checkpoint inhibitors (ICIs) have made remarkable breakthroughs in cancer treatment. However, the widely use of ICIs is associated with a spectrum of immune-related adverse events (irAEs). These adverse events can affect any organ system. In this article, we have made a systemic review about...

Full description

Bibliographic Details
Main Authors: Jiaxin ZHOU, Qian WANG, Lian DUAN, Xiaoyan SI, Li ZHANG, Xiaowei LIU, Yue LI, Hanping WANG, Xiaoxiao GUO, Wen ZHANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2019-10-01
Series:Chinese Journal of Lung Cancer
Subjects:
Immune checkpoint inhibitors
Immune-related adverse events
Rheumatic disease
Treatment
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2019.10.12

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2019.10.12

Similar Items